2014
Adjuvant valproate therapy for patients with suspected mixed-depressive features
Liu C. Adjuvant valproate therapy for patients with suspected mixed-depressive features. Therapeutic Advances In Psychopharmacology 2014, 4: 143-148. PMID: 25083273, PMCID: PMC4104709, DOI: 10.1177/2045125314532868.Peer-Reviewed Original ResearchResistance to antidepressant therapyTolerability of mood stabilizersValproate therapyAdverse eventsRisk of suicideTreatment-emergent adverse eventsPsychiatric outpatientsAntidepressant therapyMood stabilizersBipolar disorderMood disordersTreated with valproateRetrospective observational studyReviewed medical recordsCourse of treatmentAggravation of symptomsStopping valproateTreatment responseAdjuvant therapyValproatePatient demographicsClinical entityClinical profileTreated patientsBipolar
2013
Aripiprazole for Drug-Naive or Antipsychotic-Short-Exposure Subjects With Ultra-High Risk State and First-Episode Psychosis
Liu C, Chien Y, Hsieh M, Hwang T, Hwu H, Liu C. Aripiprazole for Drug-Naive or Antipsychotic-Short-Exposure Subjects With Ultra-High Risk State and First-Episode Psychosis. Journal Of Clinical Psychopharmacology 2013, 33: 18-23. PMID: 23277261, DOI: 10.1097/jcp.0b013e31827cb017.Peer-Reviewed Original ResearchConceptsFirst-episode psychosisUltra-high riskFirst-episode psychosis patientsDrug-naiveUltra-high risk stateUltra-high-risk patientsLow-dose aripiprazoleNegative symptom scoresPositive symptom scoresFlexible dosing strategyState of psychosisTreatment responseAntipsychotic therapyDrug-naive populationSevere psychopathologyUHR patientsFirst-episodeAripiprazoleAdverse eventsSymptom scoresPsychosisRisk stateConcomitant medicationsTarget doseClinical improvement